Dave Schuette Joins DataJoint Board of Directors [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
HOUSTON March 12, 2026 /PRNewswire/ -- DataJoint, the scientific data infrastructure company enabling defensible and reproducible AI in regulated R&D, today announced that Dave Schuette has joined its Board of Directors as an independent member. The appointment strengthens DataJoint's leadership as the company expands into pharmaceutical and life sciences markets following the recent launch of its Agentic AI platform. Standard DataJoint Logo with Name (PRNewsfoto/DataJoint) Schuette is the founder and managing partner of Slide3 , a boutique consulting firm serving pharmaceutical, financial services, and technology clients. With more than 25 years of experience as a business management executive, he brings a track record of transforming organizations and creating disruptive operational strategies at scale. Prior to founding Slide3 in 2018, Schuette served as EVP and President of the Enterprise Business Unit at Synchronoss Technologies , leading growth across healthcare and life
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb (BMY) had its price target raised by HSBC Holdings plc from $53.00 to $60.00. They now have a "hold" rating on the stock.MarketBeat
- Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference [Yahoo! Finance]Yahoo! Finance
- Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Defense Lifts Moat Stocks As Tech Stumbles [Seeking Alpha]Seeking Alpha
- ???????(JAK)?????????????(2026?~2036?) [CNET News]CNET News
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- BMY's page on the SEC website